Michael Zinda is EVP, CHIEF SCIENTIFIC OFFICER of Repare Therapeutics Inc.. Currently has a direct ownership of 71,908 shares of RPTX, which is worth approximately $243,768. The most recent transaction as insider was on Apr 01, 2024, when has been sold 410 shares (Common Shares) at a price of $4.66 per share, resulting in proceeds of $1,910. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 71.9K
0% 3M change
19.61% 12M change
Total Value Held $243,768

Michael Zinda Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2024
SELL
Open market or private sale
$1,910 $4.66 p/Share
410 Reduced 0.57%
71,908 Common Shares
Mar 28 2024
SELL
Open market or private sale
$2,088 $4.64 p/Share
450 Reduced 0.62%
72,318 Common Shares
Mar 27 2024
SELL
Open market or private sale
$2,079 $4.62 p/Share
450 Reduced 0.61%
72,768 Common Shares
Mar 26 2024
SELL
Open market or private sale
$2,074 $4.61 p/Share
450 Reduced 0.61%
73,218 Common Shares
Mar 25 2024
SELL
Open market or private sale
$2,151 $4.78 p/Share
450 Reduced 0.61%
73,668 Common Shares
Mar 01 2024
BUY
Grant, award, or other acquisition
-
14,000 Added 15.89%
74,118 Common Shares
Jun 08 2023
BUY
Open market or private sale
$34,485 $12.02 p/Share
2,869 Added 4.55%
60,118 Common Shares
Jun 07 2023
SELL
Open market or private sale
$77,040 $12.03 p/Share
6,404 Reduced 9.23%
62,987 Common Shares
Jun 06 2023
SELL
Open market or private sale
$14,447 $12.04 p/Share
1,200 Reduced 1.7%
69,391 Common Shares
Jan 30 2023
BUY
Grant, award, or other acquisition
-
24,550 Added 25.8%
70,591 Common Shares
Mar 15 2022
SELL
Open market or private sale
$6,023 $11.3 p/Share
533 Reduced 1.14%
46,041 Common Shares
Nov 23 2021
BUY
Exercise of conversion of derivative security
$89,320 $1.94 p/Share
46,041 Added 49.71%
46,574 Common Shares
Nov 15 2021
SELL
Open market or private sale
$550,800 $27.54 p/Share
20,000 Reduced 97.4%
533 Common Shares
Aug 16 2021
SELL
Open market or private sale
$513,150 $34.21 p/Share
15,000 Reduced 42.21%
20,533 Common Stock
May 17 2021
SELL
Open market or private sale
$487,200 $32.48 p/Share
15,000 Reduced 29.68%
35,533 Common Stock
Dec 29 2020
SELL
Open market or private sale
$675,770 $34.31 p/Share
19,696 Reduced 28.05%
50,533 Common Stock
Dec 28 2020
SELL
Open market or private sale
$517,952 $34.42 p/Share
15,048 Reduced 17.65%
70,229 Common Stock
Dec 28 2020
BUY
Exercise of conversion of derivative security
$99 $2.06 p/Share
48 Added 0.06%
85,277 Common Stock
Dec 24 2020
SELL
Open market or private sale
$14,316 $33.14 p/Share
432 Reduced 0.5%
85,229 Common Stock
Dec 24 2020
BUY
Exercise of conversion of derivative security
$890 $2.06 p/Share
432 Added 0.5%
85,661 Common Stock
Dec 23 2020
SELL
Open market or private sale
$549,879 $33.87 p/Share
16,235 Reduced 16.0%
85,229 Common Stock
Dec 23 2020
BUY
Exercise of conversion of derivative security
$33,119 $2.04 p/Share
16,235 Added 13.79%
101,464 Common Stock
Dec 22 2020
SELL
Open market or private sale
$1,391,388 $33.68 p/Share
41,312 Reduced 32.65%
85,229 Common Stock
Dec 22 2020
BUY
Exercise of conversion of derivative security
$76,427 $1.85 p/Share
41,312 Added 24.61%
126,541 Common Stock
Dec 21 2020
SELL
Open market or private sale
$1,323,200 $33.08 p/Share
40,000 Reduced 31.94%
85,229 Common Stock
MZ

Michael Zinda

EVP, CHIEF SCIENTIFIC OFFICER
St Laurent, A8

Track Institutional and Insider Activities on RPTX

Follow Repare Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RPTX shares.

Notify only if

Insider Trading

Get notified when an Repare Therapeutics Inc. insider buys or sells RPTX shares.

Notify only if

News

Receive news related to Repare Therapeutics Inc.

Track Activities on RPTX